Ocugen Gains FDA Alignment on Key Aspects of OCU400 —Modifier Gene Therapy

MALVERN, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) OCGN, a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Company received alignment from FDA on key aspects of the…#malvern #ocugeninc #ocugen #fda #rho #retinitispigmentosa #shankarmusunuri #cofounderof #phase12 #rp
Source: Reuters: Health - Category: Consumer Health News Source Type: news